Tuesday, 02 January 2024 12:17 GMT

Dr. Scott Grady Making Thyroid RFA More Accessible In Oregon


(MENAFN- PR Newswire) Thyroid RFA offers a scar-free solution to symptoms such as difficulty swallowing, discomfort, and cosmetic concerns. Clinical studies show that patients can experience up to an 80% reduction in nodule size within a year , all without the risks associated with surgery or the need for lifelong hormone therapy.

"Since introducing RFA, I've seen how it provides patients with excellent results while avoiding surgery," says Dr. Grady. "With minimal downtime and expanding insurance coverage, this treatment is a game-changer for thyroid care."

Additionally, insurance coverage is now available for Thyroid RFA , making this treatment more accessible to patients. Coverage varies based on individual insurance plans, and patients are encouraged to check with their provider regarding eligibility.

The in-office procedure is performed under local anesthesia, typically lasting 30–60 minutes , depending on the size of the nodule. Patients remain under observation for an additional 60–120 minutes before discharge. Dr. Grady uses STARmed's industry-leading RF technology to ensure the highest standard of care with the most clinically proven system. STARmed RF System is the only RF technology featured in over 80% of all thyroid RFA clinical studies, demonstrating its unmatched safety and efficacy in treating benign thyroid nodules.

As more people seek non-surgical thyroid treatments , RFA is becoming a preferred option among physicians and patients.

Schedule a Consultation

For more information or to book an appointment, visit Portland Diabetes & Endocrinology Center or call (503) 297-3336 . The clinic is located at 9135 SW Barnes Rd, Suite 985, Portland, OR 97225 .

About Portland Diabetes & Endocrinology Center

Founded in the 1920s, Portland Diabetes & Endocrinology Center (PDEC) is one of the largest and most established private endocrinology clinics in the United States. PDEC has been a pioneer in research and innovation for the treatment of endocrine disorders, continuously advancing patient care in diabetes, thyroid conditions, and metabolic diseases.

SOURCE Portland Diabetes & Endocrinology Center (PDEC)

MENAFN25022025003732001241ID1109246936



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search